TY - JOUR PY - 2018 DA - 2018// TI - Global prevalence, treatment, and prevention of hepatitis B virus infection in 2016: a modelling study JO - Lancet Gastroenterol Hepatol VL - 3 UR - https://doi.org/10.1016/S2468-1253(18)30056-6 DO - 10.1016/S2468-1253(18)30056-6 ID - ref1 ER - TY - JOUR AU - Wang, J. AU - Shen, T. AU - Huang, X. PY - 2016 DA - 2016// TI - Serum hepatitis B virus RNA is encapsidated pregenome RNA that may be associated with persistence of viral infection and rebound JO - J Hepatol VL - 65 UR - https://doi.org/10.1016/j.jhep.2016.05.029 DO - 10.1016/j.jhep.2016.05.029 ID - Wang2016 ER - TY - JOUR AU - Terrault, N. A. AU - Lok, A. S. F. AU - McMahon, B. J. PY - 2018 DA - 2018// TI - Update on prevention, diagnosis, and treatment of chronic hepatitis B: AASLD 2018 hepatitis B guidance JO - Hepatology. VL - 67 UR - https://doi.org/10.1002/hep.29800 DO - 10.1002/hep.29800 ID - Terrault2018 ER - TY - JOUR PY - 2017 DA - 2017// TI - Electronic address eee, European Association for the Study of the L. EASL 2017 Clinical Practice Guidelines on the management of hepatitis B virus infection JO - J Hepatol VL - 67 UR - https://doi.org/10.1016/j.jhep.2017.03.021 DO - 10.1016/j.jhep.2017.03.021 ID - ref4 ER - TY - JOUR AU - Biron, C. A. PY - 2001 DA - 2001// TI - Interferons alpha and beta as immune regulators--a new look JO - Immunity. VL - 14 UR - https://doi.org/10.1016/S1074-7613(01)00154-6 DO - 10.1016/S1074-7613(01)00154-6 ID - Biron2001 ER - TY - JOUR AU - Ma, H. AU - Zhang, H. H. AU - Wei, L. PY - 2013 DA - 2013// TI - Frequency of T-cell FoxP3(+) Treg and CD4(+)/CD8(+) PD-1 expression is related to HBeAg seroconversion in hepatitis B patients on pegylated interferon JO - Chin Med J (Engl) VL - 126 ID - Ma2013 ER - TY - JOUR AU - Fletcher, S. P. AU - Chin, D. J. AU - Gruenbaum, L. PY - 2015 DA - 2015// TI - Intrahepatic transcriptional signature associated with response to interferon-alpha treatment in the woodchuck model of chronic hepatitis B JO - PLoS Pathog VL - 11 UR - https://doi.org/10.1371/journal.ppat.1005103 DO - 10.1371/journal.ppat.1005103 ID - Fletcher2015 ER - TY - JOUR AU - Gonzalez-Navajas, J. M. AU - Lee, J. AU - David, M. AU - Raz, E. PY - 2012 DA - 2012// TI - Immunomodulatory functions of type I interferons JO - Nat Rev Immunol VL - 12 UR - https://doi.org/10.1038/nri3133 DO - 10.1038/nri3133 ID - Gonzalez-Navajas2012 ER - TY - JOUR AU - Swiecki, M. AU - Colonna, M. PY - 2011 DA - 2011// TI - Type I interferons: diversity of sources, production pathways and effects on immune responses JO - Curr Opin Virol VL - 1 UR - https://doi.org/10.1016/j.coviro.2011.10.026 DO - 10.1016/j.coviro.2011.10.026 ID - Swiecki2011 ER - TY - JOUR AU - Thimme, R. AU - Dandri, M. PY - 2013 DA - 2013// TI - Dissecting the divergent effects of interferon-alpha on immune cells: time to rethink combination therapy in chronic hepatitis B? JO - J Hepatol VL - 58 UR - https://doi.org/10.1016/j.jhep.2012.11.007 DO - 10.1016/j.jhep.2012.11.007 ID - Thimme2013 ER - TY - JOUR AU - Micco, L. AU - Peppa, D. AU - Loggi, E. PY - 2013 DA - 2013// TI - Differential boosting of innate and adaptive antiviral responses during pegylated-interferon-alpha therapy of chronic hepatitis B JO - J Hepatol VL - 58 UR - https://doi.org/10.1016/j.jhep.2012.09.029 DO - 10.1016/j.jhep.2012.09.029 ID - Micco2013 ER - TY - JOUR AU - Tang, T. J. AU - Kwekkeboom, J. AU - Mancham, S. PY - 2005 DA - 2005// TI - Intrahepatic CD8+ T-lymphocyte response is important for therapy-induced viral clearance in chronic hepatitis B infection JO - J Hepatol VL - 43 UR - https://doi.org/10.1016/j.jhep.2005.01.038 DO - 10.1016/j.jhep.2005.01.038 ID - Tang2005 ER - TY - JOUR AU - Cho, H. AU - Kang, H. AU - Lee, H. H. AU - Kim, C. W. PY - 2017 DA - 2017// TI - Programmed cell death 1 (PD-1) and cytotoxic T lymphocyte-associated antigen 4 (CTLA-4) in viral hepatitis JO - Int J Mol Sci VL - 18 UR - https://doi.org/10.3390/ijms18071517 DO - 10.3390/ijms18071517 ID - Cho2017 ER - TY - JOUR AU - Said, E. A. AU - Al-Reesi, I. AU - Al-Riyami, M. PY - 2016 DA - 2016// TI - Increased CD86 but not CD80 and PD-L1 expression on liver CD68+ cells during chronic HBV infection JO - PLoS One VL - 11 UR - https://doi.org/10.1371/journal.pone.0158265 DO - 10.1371/journal.pone.0158265 ID - Said2016 ER - TY - JOUR AU - Said, E. A. AU - Al-Reesi, I. AU - Al-Riyami, M. PY - 2016 DA - 2016// TI - A potential inhibitory profile of liver CD68+ cells during HCV infection as observed by an increased CD80 and PD-L1 but not CD86 expression JO - PLoS One VL - 11 UR - https://doi.org/10.1371/journal.pone.0153191 DO - 10.1371/journal.pone.0153191 ID - Said2016 ER - TY - JOUR AU - Boltjes, A. AU - Movita, D. AU - Boonstra, A. AU - Woltman, A. M. PY - 2014 DA - 2014// TI - The role of Kupffer cells in hepatitis B and hepatitis C virus infections JO - J Hepatol VL - 61 UR - https://doi.org/10.1016/j.jhep.2014.04.026 DO - 10.1016/j.jhep.2014.04.026 ID - Boltjes2014 ER - TY - JOUR AU - Imamura, M. AU - Ogawa, T. AU - Sasaguri, Y. AU - Chayama, K. AU - Ueno, H. PY - 2005 DA - 2005// TI - Suppression of macrophage infiltration inhibits activation of hepatic stellate cells and liver fibrogenesis in rats JO - Gastroenterology. VL - 128 UR - https://doi.org/10.1053/j.gastro.2004.10.005 DO - 10.1053/j.gastro.2004.10.005 ID - Imamura2005 ER - TY - JOUR AU - Karlmark, K. R. AU - Weiskirchen, R. AU - Zimmermann, H. W. PY - 2009 DA - 2009// TI - Hepatic recruitment of the inflammatory Gr1+ monocyte subset upon liver injury promotes hepatic fibrosis JO - Hepatology. VL - 50 UR - https://doi.org/10.1002/hep.22950 DO - 10.1002/hep.22950 ID - Karlmark2009 ER - TY - JOUR AU - Bedossa, P. AU - Poynard, T. PY - 1996 DA - 1996// TI - An algorithm for the grading of activity in chronic hepatitis C. The METAVIR Cooperative Study Group JO - Hepatology VL - 24 UR - https://doi.org/10.1002/hep.510240201 DO - 10.1002/hep.510240201 ID - Bedossa1996 ER - TY - JOUR AU - Oliviero, B. AU - Varchetta, S. AU - Paudice, E. PY - 2009 DA - 2009// TI - Natural killer cell functional dichotomy in chronic hepatitis B and chronic hepatitis C virus infections JO - Gastroenterology VL - 137 UR - https://doi.org/10.1053/j.gastro.2009.05.047 DO - 10.1053/j.gastro.2009.05.047 ID - Oliviero2009 ER - TY - JOUR AU - Tjwa, E. T. AU - Oord, G. W. AU - Hegmans, J. P. AU - Janssen, H. L. AU - Woltman, A. M. PY - 2011 DA - 2011// TI - Viral load reduction improves activation and function of natural killer cells in patients with chronic hepatitis B JO - J Hepatol VL - 54 UR - https://doi.org/10.1016/j.jhep.2010.07.009 DO - 10.1016/j.jhep.2010.07.009 ID - Tjwa2011 ER - TY - JOUR AU - Cooper, A. AU - Tal, G. AU - Lider, O. AU - Shaul, Y. PY - 2005 DA - 2005// TI - Cytokine induction by the hepatitis B virus capsid in macrophages is facilitated by membrane heparan sulfate and involves TLR2 JO - J Immunol VL - 175 UR - https://doi.org/10.4049/jimmunol.175.5.3165 DO - 10.4049/jimmunol.175.5.3165 ID - Cooper2005 ER - TY - JOUR AU - Hosel, M. AU - Quasdorff, M. AU - Wiegmann, K. PY - 2009 DA - 2009// TI - Not interferon, but interleukin-6 controls early gene expression in hepatitis B virus infection JO - Hepatology. VL - 50 UR - https://doi.org/10.1002/hep.23226 DO - 10.1002/hep.23226 ID - Hosel2009 ER - TY - JOUR AU - Martrus, G. AU - Goebels, H. AU - Langeneckert, A. E. PY - 2019 DA - 2019// TI - CD49a expression identifies a subset of intrahepatic macrophages in humans JO - Front Immunol VL - 10 UR - https://doi.org/10.3389/fimmu.2019.01247 DO - 10.3389/fimmu.2019.01247 ID - Martrus2019 ER -